» Articles » PMID: 33481206

Current Challenges Faced by Cancer Clinical Trials in Addressing the Problem of Under-Representation of Older Adults: A Narrative Review

Overview
Journal Oncol Ther
Specialty Oncology
Date 2021 Jan 22
PMID 33481206
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The number of older adults living with cancer is increasing. There is a clear lack of representation of older adults in clinical trials, including cancer trials. Reasons for this are multifactorial and complex and include protocol, patient and sponsor factors. Potential solutions to overcome issues with trial design include varied methods of recruitment with flexible inclusion criteria. Possible alternatives to randomised trials include prospective cohort studies, pragmatic trials and the use of national population-based data sets. Patient factors may be addressed by integration of geriatric assessment, so patients can be randomised or treated based on their individual needs. Additionally, standard protocols for including older adults with cognitive impairment should be developed, rather than automatic exclusion. Increased effort is needed from sponsors and governing health care bodies to make recruitment of older adults to clinical trials standard.

Citing Articles

Clinical trials in older patients with cancer - typical challenges, possible solutions, and a paradigm of study design in breast cancer.

Karihtala P, Schiza A, Fountzilas E, Geisler J, Meattini I, Risi E Acta Oncol. 2024; 63:441-447.

PMID: 38881342 PMC: 11332548. DOI: 10.2340/1651-226X.2023.40365.


Equality, diversity, and inclusion in oncology clinical trials: an audit of essential documents and data collection against INCLUDE under-served groups in a UK academic trial setting.

Patel D, Kilburn L, Fox L, Hall E, Bliss J, Lewis R BMC Med Ethics. 2023; 24(1):105.

PMID: 38017503 PMC: 10685485. DOI: 10.1186/s12910-023-00987-w.


A nomogram for predicting breast cancer specific survival in elderly patients with breast cancer: a SEER population-based analysis.

Yang R, Wu Y, Qi Y, Liu W, Huang Y, Zhao X BMC Geriatr. 2023; 23(1):594.

PMID: 37749538 PMC: 10518930. DOI: 10.1186/s12877-023-04280-8.


Optimizing clinical nutrition research: the role of adaptive and pragmatic trials.

Orsso C, Ford K, Kiss N, Trujillo E, Spees C, Hamilton-Reeves J Eur J Clin Nutr. 2023; 77(12):1130-1142.

PMID: 37715007 PMC: 10861156. DOI: 10.1038/s41430-023-01330-7.


Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study).

Lehtomaki K, Soveri L, Osterlund E, Lamminmaki A, Uutela A, Heerva E J Clin Med. 2023; 12(10).

PMID: 37240646 PMC: 10218996. DOI: 10.3390/jcm12103541.


References
1.
Muss H, Woolf S, Berry D, Cirrincione C, Weiss R, Budman D . Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA. 2005; 293(9):1073-81. DOI: 10.1001/jama.293.9.1073. View

2.
Mody L, Miller D, McGloin J, Freeman M, Marcantonio E, Magaziner J . Recruitment and retention of older adults in aging research. J Am Geriatr Soc. 2008; 56(12):2340-8. PMC: 2695395. DOI: 10.1111/j.1532-5415.2008.02015.x. View

3.
van der Willik K, Schagen S, Ikram M . Cancer and dementia: Two sides of the same coin?. Eur J Clin Invest. 2018; 48(11):e13019. PMC: 6220770. DOI: 10.1111/eci.13019. View

4.
Harris T, Carey I, Victor C, Adams R, Cook D . Optimising recruitment into a study of physical activity in older people: a randomised controlled trial of different approaches. Age Ageing. 2008; 37(6):659-65. DOI: 10.1093/ageing/afn159. View

5.
Saini K, de Las Heras B, Plummer R, Moreno V, Romano M, de Castro J . Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms. JCO Glob Oncol. 2020; 6:1357-1362. PMC: 7529519. DOI: 10.1200/GO.20.00346. View